RIGEL PHARMACEUTICALS INC - COM NEW (RIGL)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
733
Holdings value Q3 2024
$11.8K
Value change Q3 2024
-$5.41K
Grand Portfolio weight change Q3 2024
0%
Number of holders
4
Number of buys Q3 2024
1
Number of sells Q3 2024
-3
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 733 $11.8K -$5.41K $16.09 4
2024 Q2 1.96K $2.31K -$164M $1.48 5
2024 Q1 111M $164M +$6.46M $1.48 113
2023 Q4 107M $155M +$571K $1.45 110
2023 Q3 106M $115M -$5.31M $1.08 104
2023 Q2 111M $143M -$2.53M $1.29 116
2023 Q1 113M $149M +$4.9M $1.32 121
2022 Q4 109M $163M -$25.6M $1.50 113
2022 Q3 127M $149M -$13.7M $1.18 128
2022 Q2 139M $157M -$32.3M $1.13 125
2022 Q1 135M $406M -$6.98M $2.99 158
2021 Q4 138M $366M -$5.55M $2.65 156
2021 Q3 138M $499M -$15.4M $3.63 158
2021 Q2 142M $614M -$9.02M $4.34 155
2021 Q1 144M $493M +$14.2M $3.42 144
2020 Q4 140M $490M -$4M $3.50 143
2020 Q3 140M $335M -$9.17M $2.40 136
2020 Q2 145M $265M -$7.15M $1.83 131
2020 Q1 147M $229M +$2.11M $1.56 119
2019 Q4 148M $316M +$462K $2.14 129
2019 Q3 148M $276M -$7.25M $1.87 125
2019 Q2 151M $392M +$2.23M $2.61 123
2019 Q1 155M $399M -$7.65M $2.57 126
2018 Q4 159M $365M +$1.16M $2.30 128
2018 Q3 157M $503M -$699K $3.21 134
2018 Q2 158M $447M +$53.3M $2.83 128
2018 Q1 139M $490M +$7.66M $3.54 116
2017 Q4 136M $528M +$105M $3.88 119
2017 Q3 109M $278M -$964K $2.54 104
2017 Q2 109M $299M +$3.74M $2.73 108
2017 Q1 108M $357M +$88.6M $3.31 97
2016 Q4 88.3M $210M -$4.2M $2.38 102
2016 Q3 86.7M $318M +$18M $3.67 117
2016 Q2 83.7M $187M +$5.01M $2.23 116
2016 Q1 81.5M $170M -$6.04M $2.08 117
2015 Q4 81.8M $248M +$5.71M $3.03 119
2015 Q3 79.7M $197M +$2.27M $2.47 116
2015 Q2 78.8M $253M +$7.15M $3.21 119
2015 Q1 75.8M $271M +$4.19M $3.57 109
2014 Q4 76M $172M -$6.16M $2.27 90
2014 Q3 78.7M $153M +$3.67M $1.94 98
2014 Q2 75.7M $275M -$1.33M $3.63 97
2014 Q1 77.5M $300M -$4.74M $3.88 108